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Abstract
The SMILES trial showed substantial improvement of
depressive symptoms following seven consultations on
healthy dieting. The very large effect size on depression
reduction seems remarkable and we suggest that
selectively induced expectancy and a loss of blinding
have contributed to the observed effect.
The recently published SMILES study [1] is the first ran-
domized controlled trial (RCT) to assess the efficacy of a
manipulated diet on depression, extending previous stud-
ies on single nutrients. The authors conclude that “… diet-
ary improvement guided by a clinical dietician may
provide an efficacious treatment strategy for the manage-
ment of this highly prevalent mental disorder” ([1], p. 1),
and that “clinicians should […] consider promoting the
benefits of dietary improvement and facilitating access to
dietetics support for their patients with depression” ([1], p.
11). At the same time, the authors acknowledge the need
for replication while referring to the small sample size of
their study (N = 56; about one-third of the sample size
pre-specified as required for adequate power).
Studying the effects of diet on depression is of consid-
erable public interest [1–4], and we agree that the topic
warrants attention. However, we argue below that the re-
sults of the SMILES study should not be taken as evi-
dence for diet efficacy given various issues regarding
study recruitment and blinding. In the SMILES study,
participants were randomized to seven sessions of either
dietary support or social support. The dietary condition
outperformed the control condition (social support)
with an effect size (Cohen’s d) of 1.2, which is four
to five times larger than established depression
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treatments (e.g., cognitive behavioral therapy, d = 0.2–0.3
[5]; antidepressants, d = 0.3 [6, 7]). The pre–post effect
size of the diet condition was very large (d = 1.98),
whereas the social support condition had an effect size of
d = 0.63.
Since its publication, the SMILES trial has received
considerable attention [8, 9], likely due to the very large
effect and the conclusion from SMILES’ senior author in
a follow-up article that the trial provides “… intervention
evidence supporting causality [for dietary improvement
as a treatment strategy for major depressive episodes]”
([4], p. 26). This aligns with other work by some of the
SMILES trial team members in which diet and nutrition
are conceptualized as a “… central determinant of men-
tal health” ([2], p. 271).
The primary outcome in the SMILES trial was change
in the severity of depression symptoms, in this case
assessed via the interviewer-rated Montgomery–Åsberg
Depression Rating Scale (MADRS) [10]. Such outcomes
are subjective in nature (the participant is queried about
symptoms), and thus susceptible to expectancy effects
(defined as results biased by the communication of the
expected results [11–14]). When the intervention is
non-pharmacological – herein the advice of following a
healthy diet – the blinding of conditions in an RCT is
hardly possible. In order to minimize expectancy bias,
the authors describe that they masked the hypothesis
and used a neutral recruitment strategy. Participants
were approached (in social media, local newspapers, and
radio interviews) with the following message: “We are
trialing the effect of an educational and counseling pro-
gram focusing on diet that may help improve the symp-
toms of depression” ([1], p. 2). The paper further states
that “several strategies were employed to reduce the risk
of bias” ([1], p. 5) and that “significant effort was made
to mask our hypothesis” ([1], p. 10).
In this letter, we argue that there is a mismatch be-
tween the reported and the actual recruitment strategy,
which becomes clear when comparing the reported and
actual recruitment strategies. Through a hyperlink to an
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external website on the study’s recruitment website [15]
(note that there are some differences with current and
previous versions), potential participants are presented
to a ‘fruit smiley’, composed out of two green apples as
eyes, a mandarin as nose, and a banana with the edges
pointing up as a smiling mouth [16]. Messages such as:
“Bananas look like a smile but can also help you smile
because they contain tryptophan which is a mood
stabilizer” and “Banana, brazil nuts, broccoli, they all
have something in common apart from starting with the
letter B. They all contain nutrients which can stabilize
mood” are presented alongside. Since no benefits of the
control conditioning (befriending) were described, we
think that this is anything but a neutral description,
which has likely affected expectancy in participants. The
study hypothesis was provided at recruitment to poten-
tial participants ‘on a platter’, so to speak. Website visi-
tors also learned that “the fear that we are eating our
way to depression is prompting governments to take ac-
tion” [15]. This was accompanied by testimonials, such
as “The solution to my depression is good quality food”.
In a local newspaper article entitled ‘Diet, Depression,
Hope’ [17], published in the recruitment catchment area
at time of enrolment, the senior author wrote “if you eat
a healthier diet then it reduces your risk on depression”.
This article was accompanied by an invitation to partici-
pate in the trial and contact details. In summary, the re-
port of the SMILES trial does not seem to adequately
describe how study recruitment took place in practice.
The befriending condition had a four-time higher
drop-out rate than the dietary condition and its pre–post
effect size (d = 0.6) is lower than the effect size usually re-
ported for pill–placebo (d = 0.9) [6, 7], likely due to the se-
lective induction of expectancy. This implies that the
control condition was not perceived as an equally attractive
condition by many participants, indicating selection bias.
Given that a purpose of randomization is to prevent this
bias from happening [18], we argue that the SMILES trial
has essentially lost some of the benefits of randomization
and, further, that conclusions that can be drawn from
RCTs do not directly follow from the SMILES trial.
The SMILES trial investigators discuss that, despite the
use of blinded raters, blinding may not have been sufficient.
Additionally, the data contains evidence that blinding was
imperfect, yet this is not discussed in the article. The pre–
post effect sizes of the self-report Hospital Anxiety and
Depression Scale and the interviewer-based MADRS are
equal in the control condition. However, in the dietary con-
dition, interviewer-rated improvement is much higher than
self-reported improvement (d = 0.8 vs. d = 0 in the control
condition), suggesting a loss of blinding.
In sum, the limitations outlined above, along with
what we consider a serious mismatch between the actual
and published recruitment strategies [1], means that the
SMILES trial does not meet all criteria for an RCT. It
must be noted, however, that the notion that a healthy
diet may benefit depression has been discussed in media
prior to the SMILES trial, and not always with the most
critical scientific eye (e.g., [19]). Accordingly, Jacka et al.
[1] mention the existence of expectancy effects as a po-
tential limitation in the interpretation of the trial results.
Pre-existing expectancies make any trial more difficult
and this is certainly not the responsibility of the SMILES
investigators, yet what we do consider their responsibil-
ity is a correct description of the study procedures. We
believe that the SMILES trial falls short in this regard.
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